Connect with us

Technology

BioCentriq Partners with Orchestra Life Sciences to Advance Princeton, NJ Cell Therapy Facility Development

Published

on

Strategic Partnership to Support Facility Design and Digital Infrastructure ImplementationAccelerates Development of State-of-the-Art Advanced Therapy Manufacturing TechnologiesEnhances Operational Excellence for Clinical-to-Commercial Manufacturing Capabilities

PRINCETON, N.J., Jan. 14, 2025 /PRNewswire/ — BioCentriq, a leading cell therapy contract development and manufacturing organization (CDMO), today announced a strategic partnership with Orchestra Life Sciences (OLS), a premier technical consultancy firm specializing in advanced therapy manufacturing solutions. This collaboration supports BioCentriq’s recently announced expansion in Princeton, New Jersey, and focuses on BioCentriq’s $12M CAPEX investment for facility optimization and digital integration to enhance the site’s cell therapy development, GMP manufacturing, and testing capabilities, while delivering a customer-ready facility that upholds the highest standards of operational excellence and quality.

Orchestra Life Sciences will provide comprehensive technical expertise and strategic support for BioCentriq’s new 60,000 sq. ft. Princeton facility, announced in December 2024. The partnership encompasses multiple strategic initiatives, including the implementation of advanced manufacturing technologies, development of a fully integrated digital ecosystem, and optimization of facility design to meet the stringent regulatory requirements of cell therapy production under US FDA and EU GMP Annex 1. This collaboration strengthens BioCentriq’s position as a leading provider of cell therapy manufacturing solutions while ensuring operational excellence across all aspects of their service.

The partnership leverages Orchestra Life Sciences’ proven track record in advanced therapy facility design and infrastructure optimization. Their expertise spans various critical areas, including:

Implementation of state-of-the-art manufacturing technologies and automation solutionsDevelopment of integrated quality management systemsOptimization of process workflows and operational efficiencyEnhancement of digital infrastructure and data management capabilitiesStrategic guidance on regulatory compliance and quality assurance

“This partnership with Orchestra Life Sciences represents another significant step in our commitment to delivering best-in-class cell therapy manufacturing solutions,” said Syed T. Husain, Chairman and CEO of BioCentriq. “Their expertise in facility design, engineering solutions, and operational excellence aligns perfectly with our vision for creating a cutting-edge manufacturing center that will serve the evolving clinical- and commercial-stage needs of our clients. This collaboration will enable us to accelerate our capability and bring additional infrastructure and capacity to industry in support of innovative cell therapies.”

The collaboration will enhance BioCentriq’s ability to provide comprehensive development and manufacturing services for cell therapy innovators. Orchestra Life Sciences brings extensive experience in advanced therapy manufacturing facility design and optimization, having supported over 30 life science companies in implementing innovative solutions for complex manufacturing challenges.

“At Orchestra, we understand that the success of advanced therapies depends on creating infrastructure and systems that enable scalability without compromising quality. Partnering with BioCentriq is an exciting opportunity to apply our expertise in facility design and digital integration to advance a shared vision for operational excellence in cell therapy manufacturing,” said Emilie Pelletier, Co-Founder & CEO of Orchestra Life Sciences. “This collaboration is a major milestone, ensuring that innovative therapies can move seamlessly from clinical development to commercial delivery, ultimately improving access to life-saving treatments for patients.”

The strategic partnership will support BioCentriq’s planned facility completion and operational readiness by Q2 2025. The enhanced facility will feature state-of-the-art capabilities for cell therapy development, manufacturing, and testing, supported by advanced digital systems and optimized operational workflows. This collaboration reflects a shared vision to advance cell therapy manufacturing, addressing growing market demands and driving innovation that supports the future of advanced therapies.

For more information, visit www.biocentriq.com.

About BioCentriq
BioCentriq is a leading cell therapy contract development and manufacturing organization (CDMO) dedicated to advancing the field of cell therapy. Since 2019, the company has specialized in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials, and has evolved into an end-to-end clinical-to-commercial service provider. Operating from two U.S.-based manufacturing facilities, BioCentriq combines the flexibility and entrepreneurial spirit of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors.

About Orchestra Life Sciences
Orchestra Life Sciences (OLS) is a technical consultancy providing strategic support and scientific expertise to advance pharmaceutical therapies for cancer and rare diseases. The company specializes in engineering solutions, operational excellence, and quality compliance services for advanced therapy manufacturing facilities. Their comprehensive approach encompasses facility design, process optimization, and implementation of cutting-edge manufacturing technologies. With a focus on innovation and efficiency, OLS helps clients navigate complex technical challenges while maintaining the highest standards of quality and regulatory compliance.

For more information, please contact:
Joseph Sinclair
VP and Head of Commercial
joseph.sinclair@biocentriq.com

Emilie Pelletier
CEO & Co-Founder
Orchestra Life Sciences
info@orchestralifesciences.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/biocentriq-partners-with-orchestra-life-sciences-to-advance-princeton-nj-cell-therapy-facility-development-302350543.html

SOURCE BioCentriq, Inc.

Continue Reading

Technology

USI Unveils Wi-Fi 8 SiP Module for Enhanced AI Device Connectivity

Published

on

By

SHANGHAI, Nov. 3, 2026 /PRNewswire/ — USI today announced its Wi-Fi 8 (IEEE 802.11bn) roadmap, with product launch planned for the first quarter of 2027. Building on its Wi-Fi 6E and Wi-Fi 7 with System-in-Package (SiP) technology, USI is positioning itself to help customers capture the next wave of wireless innovation.

Wi-Fi 8 shifts focus from peak data rates to Ultra-High Reliability (UHR), efficiency, and consistent user experience. This matters as devices shrink, from smartphones and AI laptops to smart glasses, smart rings, and TWS earbuds, and must maintain stable connections despite limited antenna space, constrained battery capacity, and complex RF environments.

Key Wi-Fi 8 technologies include:

Multi-AP Coordination: Coordinated Beamforming (Co-BF) and Coordinated Spatial Reuse (Co-SR)Dynamic Spectrum Optimization: Dynamic Sub-channel Operation (DSO)PHY enhancements: Distributed Resource Unit (DRU), Enhanced Long Range (ELR), and Unequal Modulation (UEQM)

Together, these advances enable smarter, more coordinated wireless networks and extend advanced connectivity to wearables and next-generation robotics.

Shrinking form factors bring tighter space, battery, thermal, and power demands. USI draws on deep expertise in SiP design, RF engineering, wireless module integration, advanced packaging, and high-volume manufacturing to help customers reduce product size, optimize power consumption, and simplify system design. Its Wi-Fi 6E and Wi-Fi 7 SiP miniaturization, combined with advanced RF and shielding technologies, provides a strong base for the Wi-Fi 8 transition.

Wi-Fi 8 is also expected to drive deeper system-level integration across wireless ICs, RF front-end components, antennas, power management, and advanced packaging, so that wireless performance and miniaturization evolve together in wearable, mobile, and IoT products.

“Wi-Fi 8 is about more than faster speeds. It is about enabling devices to maintain reliable, consistent, and predictable connections in complex wireless environments. USI will combine its capabilities in wireless connectivity, RF design, SiP integration, and advanced process technology to help customers overcome the challenges of product miniaturization and rising system complexity, accelerating the time to market for next-generation smart devices.” said Jessica Yu, Associate Vice President of Wireless & Wearable Miniaturization Solutions at USI.

Wi-Fi 6 and 6E improved network efficiency and expanded available spectrum, and Wi-Fi 7 significantly raised throughput, bandwidth, and responsiveness. Wi-Fi 8 goes further, delivering greater reliability, predictability, and efficiency in increasingly complex wireless environments.

About USI (601231.SH)

USI, Universal Scientific Industrial (Shanghai) Co., Ltd., is a global leader in electronic design and manufacturing as well as a leader in the field of SiP (System-in-Package) technology. Our production and service locations span four continents: Asia, Europe, the Americas, and Africa, offering customer diversified electronic products with D(MS)2 services: Design, Manufacturing, Miniaturization, Industrial software, and hardware Solutions, as well as material procurement, logistics and maintenance Services. USI is a subsidiary of ASE Technology Holding Co., Ltd. (TWSE: 3711, NYSE: ASX). To learn more, please visit www.usiglobal.com and engage with us on LinkedIn and YouTube.

View original content:https://www.prnewswire.com/apac/news-releases/usi-unveils-wi-fi-8-sip-module-for-enhanced-ai-device-connectivity-302924735.html

SOURCE USI

Continue Reading

Technology

Camect and 3Si: Strategic Partnership to Bring AI-Powered Video Intelligence Directly to Public Safety

Published

on

By

New integration connects Camect’s intelligent video detection and 3Si’s DirectToDispatch™ platform, delivering actionable incident intelligence to public safety when every second counts.

MOUNTAIN VIEW, Calif., Nov. 2, 2026 /PRNewswire/ — Camect, an innovator in AI-powered video intelligence and intelligent security camera technology, today announced a strategic technology partnership with 3Si Security Systems, a trusted provider of security intelligence solutions for public safety and private-sector organizations.

Camect and 3Si connect AI video detection with DirectToDispatch™ to deliver actionable public safety intelligence.

The partnership connects Camect’s advanced AI-powered video intelligence with 3Si’s award-winning DirectToDispatch™ platform, creating a more direct pathway between intelligent security detection and public safety response.

By combining Camect’s ability to identify relevant activity across existing security camera systems and 3Si’s established public safety intelligence network, the companies are working together to transform how critical incident information reaches the people responsible for protecting communities. Request a demo today to see Camect’s powerful capabilties first hand!

Connecting Video Intelligence to Public Safety Response

Across businesses, commercial properties, and communities, security cameras capture enormous amounts of video every day. However, identifying meaningful activity and turning that information into actionable intelligence remains a challenge.

Camect’s AI-powered video analysis addresses this challenge by detecting relevant activity, minimizing unnecessary alerts, and providing meaningful visual context. Through the partnership with 3Si, Camect intelligence can extend beyond traditional security monitoring into public safety workflows.

3Si’s DirectToDispatch™ platform creates a connection between private-sector security intelligence and public safety agencies, supporting the delivery of actionable incident information when it matters most.

Together, Camect and 3Si aim to help bridge the gap between detecting an incident and enabling a more informed response.

“This integration with 3Si empowers our dealers and the communities they serve to maintain control of their video data while securely sharing relevant information with the people who need it most: our first responders,” said Ron Grubbs, VP of Sales Business Development at Camect. “3Si has been a trusted partner in public safety for decades, and we are incredibly proud to work alongside them to help strengthen community safety and support those on the front lines.”

From intelligent detection to actionable dispatch intelligence, Camect and 3Si share a vision of a future where security technology doesn’t simply capture what happens, it helps the right people understand and respond to it.

About Camect

Camect is a Silicon Valley-based technology company specializing in AI-powered video intelligence and advanced security camera solutions. Designed to make existing camera systems smarter, Camect transforms ordinary security cameras into intelligent tools capable of identifying meaningful activity with over 40 advanced detections and features, reducing false alerts, and delivering actionable video insights in real time.

With a camera-agnostic approach, privacy-focused architecture, and support for professional monitoring, Real-Time Crime Centers (RTCCs), and Emergency Communications Centers (ECCs), Camect helps businesses, security professionals, and public safety organizations gain greater value from their existing video infrastructure with over 30 integrations and growing.

Headquartered in Mountain View, California, Camect is committed to making intelligent video security more accessible, connected, and effective.

Request a demo today of Camect’s advanced detections and features, visit Camect.com

Learn more about this integration visit www.camect.com.

About 3Si Security Systems

3Si is a leading provider of innovative security solutions, dedicated to creating a safer, more secure world. The company combines technology with real-world experience to deliver an intelligent platform that protects people, assets, and law enforcement while enabling informed, real-time decision-making.

With relationships spanning more than 10,400 law enforcement agencies, 3Si delivers actionable crime intelligence directly to police dispatch for crime prioritization and response. Its integrated technology portfolio includes covert GPS tracking, camera and video solutions, video management technology, and its award-winning DirectToDispatch™ platform.

From detection to dispatch, every second counts.

Learn more at www.3sisecurity.com

CONTACT:
David Leon | David@Camect.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/camect-and-3si-strategic-partnership-to-bring-ai-powered-video-intelligence-directly-to-public-safety-302927050.html

SOURCE Camect

Continue Reading

Technology

TERAGO to Hold Investor Conference Call to Discuss Third Quarter 2026 Financial Results

Published

on

By

TORONTO, Nov. 2, 2026 /CNW/ — TERAGO Inc. (“TERAGO” or the “Company”) (TSX: TGO) (www.terago.ca), Canada’s 91% mmWave spectrum holder and a leading provider of Managed Fixed Wireless Internet, 5G Private Wireless Networks and SD-WAN secure solutions today announced that it will be hosting a conference call on Friday, November 13, 2026, at 10:00 a.m. ET to discuss its financial results for the third quarter of 2026. The complete financial results are expected to be released after market close on Thursday, November 12, 2026.

The Company’s results along with a presentation in connection with the conference call will be made available on the Company’s website at https://terago.ca/company/investor-relations/.

To access the conference call, please dial 888-506-0062 or 973-528-0011 and use conference ID 716685 if applicable. Please call the conference telephone number 15 minutes prior to the start time so that you are in the queue for an operator to assist in registering and patching you through.

A replay of the conference call will be available through Friday, November 27, 2026 and can be accessed by dialing 877-481-4010 or 919-882-2331 and using passcode 54732.

About TERAGO

TERAGO provides managed network and security services to businesses across Canada ensuring highly secure, reliable and redundant connectivity including private 5G wireless networks, fixed wireless access, fiber and cable wireline network connectivity. As Canada’s biggest mmWave spectrum holders, the Company possesses exclusive spectrum licenses in the 24 GHz and 38 GHz spectrum bands, which it utilizes to provide secure, dedicated SLA guaranteed enterprise grade performance that is technology diverse from buried cables ensuring high availability connectivity services. TERAGO serves Canadian and Global businesses operating in major markets across Canada, including Toronto, Montreal, Calgary, Edmonton, Vancouver, Ottawa and Winnipeg, and has been providing wireless services since 1999. For more information about TERAGO and its suite of wireless internet and SDWAN solutions, please visit www.terago.ca.

SOURCE TeraGo Inc.

Continue Reading

Trending